Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Scopus BioPharma Inc. (SCPS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.9900-0.0600 (-1.48%)
At close: 4:00PM EDT
3.9400 -0.05 (-1.25%)
After hours: 07:12PM EDT
Advertisement
Sign in to post a message.
  • s
    syed
    Scopus will not stand idly by while the company and its shareholders are victimized by short selling.
  • R
    Red Light Special
    I am so out of this if it ever hits $6 again.
  • J
    Joseph
    The problem with these short sellers is that they get to hold the bag and are allowed to short more. I want this up to 40 per share. I plan on holding for a month. Shorts I recommend you cover.
  • s
    syed
    Data from two different studies benchmark Duet’s proprietary bifunctional oligonucleotides against immune checkpoint inhibitors (“Checkpoint Inhibitors”) in lymphoma and prostate tumor models in mice
    Studies indicate Duet’s bifunctional oligonucleotides — CpG-STAT3siRNA (DUET-01) and CpG-STAT3ASO (DUET-02) — can expand reach and efficacy of cancer immunotherapies beyond the current standard-of-care treatments
  • J
    Jacqueline
    GOOD DIP BUY OPP - THIS IS GOING UP, MARK IT
  • s
    syed
    This is good news for retailers another short squeeze opportunity and the company is supporting love it buy buy buy 25%shorted

    NEW YORK, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”), a clinical-stage biopharmaceutical company, announced today that it is retaining Boies Schiller Flexner LLP to conduct a market manipulation investigation.
    In the past several weeks, the shares of Scopus BioPharma have come under attack by abusive short sellers. During this period, the short volume ratio has reached nearly 70% and over 25% of the company’s market capitalization has been wiped out. The downward pressure on the trading price of the company’s common stock has persisted despite recent positive developments.
  • T
    Talibanpicks
    RVPH a lifetime biotech gem for your portfolio guys:

    (RVPH) Market Cap $57 m--Cash $38 million --A Phase 3 biotech with MONSTER Pipeline targeting multiple blockbuster indications like Alzheimer ,Parkinson ,Depression ,ADHD and so forth / under radar low float stock = CHEAPEST Biotech out there with potential to run like SAVA which went from $3 to $130+ ...GLTA
  • C
    Chuck
    Maybe a spinoff coming?
    Bullish
  • J
    Jacqueline
    Bullish
  • C
    Chuck
    yes! go after those shorts!
    Bullish
  • J
    Jaffar
    Any news big volumes
    Bullish
  • A
    Adewale
    SCPS went up by 22% in 5 mins, any news?
    Bullish
  • s
    seanli
    lot of inside buying, but the SP keeps going down, why?
  • Y
    Yahoo Finance Insights
    Scopus BioPharma is up 17.52% to 5.50
  • W
    Wallstreetbets
    CDTX $1.69 much better biotech guys
  • Y
    Yankees Win
    Pump and Dump, no news....
  • C
    Chuck
    time to buy more
    Bullish
  • C
    Chuck
    Nice Board!
    Bullish
  • M
    MR
    Next message we will see much higher rate
    Bullish
  • P
    Peter
    Top Bullish Charts | May 2021 💰💵📈

    https://chart-analysis.tools/Bullish-Charts
    Bullish
Advertisement
Advertisement